DXCM

Q: What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is $ 62.53, with return of -19.82% compared to the last year. The price of DexCom (DXCM) started the year trading around $ 77.77 and today it is at $ 62.53. Follow the real-time price chart, the historical price of DexCom (DXCM) and international markets.

Q: When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

Q: Is DexCom (DXCM) worth it?

Currently, DexCom (DXCM) is priced at $ 62.53, with a P/E of 32.68%, representando um desvio de 8,060% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of -19.82 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -19.82%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy DexCom (DXCM) stock?

Investing in stocks of DexCom (DXCM) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -9.68% in the last month, -19.82% in the last year and -21.76% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of DexCom (DXCM) today, the total investment would be $ 6,253.00, based on the current price of $ 62.53.If past performance were to repeat, the return on your investment would be:In 1 year: $ 5,013.66In 5 years: $ 4,892.35In 10 years: $ 18,149.96It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DexCom Inc.

Price

$ 62.53

return (12m)

-19.82%

p/e

32.68

p/bv

8.64

DIVIDEND YIELD

0.00%

price DXCM

DXCM

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of DXCM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.68%

3 months

-17.00%

1 year

-19.82%

2 years

-46.18%

5 years

-21.76%

10 years

190.26%

Fundamentals DXCM

review the fundamentals of DexCom shares

P/E

32.68

Sector: -2.16 Industry: -0.67

P/SALES RATIO (PSR)

5.21

Sector: 1.99 Industry: 2.51

P/BV

8.64

Sector: 2.12 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

9.61%

Sector: -26.99% Industry: -25.01%

ROE

26.44%

Sector: -30.03% Industry: -30.75%

ROIC

21.86%

Sector: -414.93% Industry: -73.73%

NET MARGIN

15.96%

Sector: -27.97% Industry: -29.36%

GROSS MARGIN

59.01%

Sector: 44.10% Industry: 50.75%

OPERATING MARGIN

17.22%

Sector: -24.33% Industry: -25.70%

P/EBITDA

22.62

Sector: -0.32 Industry: 1.47

P/EBIT

25.67

Sector: -2.46 Industry: -1.00

P/ASSET

3.14

Sector: 1.19 Industry: 1.27

BVPS

6.97

Sector: 3.38 Industry: 4.47

EPS

1.84

Sector: -0.89 Industry: -0.87

EQUITY RATIO

0.36

Sector: 0.43 Industry: 0.45

CAGR REVENUE 5 YEARS

18.57%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

7.86%

Sector: - Industry: -

FAIR VALUE OF DexCom ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 62.53

Fair Value

$ 0.00

Upside Return potential.

-72.83%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals DXCM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	51.55	39.80	77.20%	0.55%	$ 949.16 B	30.99%
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
NVS	17.04	5.48	32.16%	3.04%	$ 245.20 B	25.53%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
GSK	12.93	4.43	34.29%	3.52%	$ 94.37 B	17.23%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

DXCM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY DexCom

DexCom Inc.

Average user rating I10

4.0 (10 people)

United States

26 years

Founded: 1999

2005

Time since IPO - 20 years

6.400

Employees

The Company DexCom Inc. (United States), is listed on Nasdaq with a market cap of $ 23.55 Billions, having an equity of $ 2.73 Billions.

With a total of 6.400 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 4.52 Billions, which generated a profit in the amount of $ 720.70 Millions.

As for its main indicators, the Company has a P/E ratio of 32.68, a P/BV ratio of 8.64 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DXCM.

Market cap

$ 23.55 Billions

Equity

$ 2.73 Billions

US$ 2,726,100,000.00

Assets

$ 7.50 Billions

US$ 7,500,000,000.00

Total Shares Outstanding

391.00 Millions

391,000,000

Average Daily Trading Volume

$ 6.95 Millions

US$ 6,952,402.02

Sector

Health

Industry

Medical Supplies and Equipment

DXCM

DXCM revenue and profits

Financial Results DXCM

DRAG THE FRAME TO SEE MORE DATA

DXCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.86 38,88% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 278.35 --15,24% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 39.46 --34,16% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 245.99 --15,59% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 50.03 7,24% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 514.76 58,85% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

LLY - Eli Lilly

$ 1,104.34 40,12% (12M)

P/E

51.55

0.55%

ROE

77.20%

P/BV

39.80

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.86 38,88% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 278.35 --15,24% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 39.46 --34,16% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 245.99 --15,59% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 50.03 7,24% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 514.76 58,85% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

LLY - Eli Lilly

$ 1,104.34 40,12% (12 M)

P/L

51.55

0.55%

ROE

77.20%

P/VP

39.80

Frequently Asked Questions

What is the price of DexCom (DXCM) today?

The price of DexCom (DXCM) today is $ 62.53, with return of -19.82% compared to the last year. The price of DexCom (DXCM) started the year trading around $ 77.77 and today it is at $ 62.53. Follow the real-time price chart, the historical price of DexCom (DXCM) and international markets.

When does DexCom (DXCM) pay dividends?

DexCom (DXCM) did not distribute dividends in the last year.

Is DexCom (DXCM) worth it?

Currently, DexCom (DXCM) is priced at $ 62.53, with a P/E of 32.68%, representando um desvio de 8,060% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of -19.82 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -19.82%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy DexCom (DXCM) stock?

Investing in stocks of DexCom (DXCM) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of DexCom (DXCM) yield today?

The yield of DexCom (DXCM) was -9.68% in the last month, -19.82% in the last year and -21.76% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of DexCom (DXCM) today, the total investment would be $ 6,253.00, based on the current price of $ 62.53.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 5,013.66
In 5 years: $ 4,892.35
In 10 years: $ 18,149.96

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

DXCM

DexCom Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of DXCM

review the fundamentals of DexCom shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY DexCom

DexCom Inc.

United States

26 years

2005

6.400

PROFIT X PRICE DXCM

Financial Results DXCM

DXCM cash flow

asset growth - DXCM

DXCM balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions